Internal Medicine, Nephrology · Marion, AR
NPI
1750501623
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1120 State Highway 77 Ste 1
Marion, AR, 72364
Phone (870) 733-1177
Groups this clinician bills Medicare through
Medicare paid, 2024
$207K
1,499 services
Medicare patients, 2024
360
Average age 69
Drug cost, 2024
$1.8M
7,069 prescriptions
Company payments, 2025
$1,078
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asif S Kazmi was code 99214 (office e&m - established), 392 times for 150 patients. In total Asif S Kazmi billed 1,499 services in 17 codes, and Medicare paid $207K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 392 | 150 | $69.21 | $27K |
| 90961 ESRD Related Services (not dialysis) | Office | 310 | 67 | $218.92 | $68K |
| 99232 Hospital E&M - Subsequent | Facility | 272 | 79 | $56.95 | $15K |
| 90960 ESRD Related Services (not dialysis) | Office | 226 | 65 | $275.93 | $62K |
| 90962 ESRD Related Services (not dialysis) | Office | 55 | 33 | $141.63 | $7,790 |
| 90966 ESRD Related Services (not dialysis) | Office | 54 | 12 | $214.11 | $12K |
| 99222 Hospital E&M - Initial | Facility | 49 | 45 | $94.74 | $4,642 |
| 99204 Office E&M - New | Office | 41 | 41 | $100.81 | $4,133 |
| 90935 Hemodialysis | Facility | 41 | 25 | $52.39 | $2,148 |
| 99213 Office E&M - Established | Office | 36 | 33 | $49.32 | $1,776 |
By year: 2022 $259K for 1,858 services; 2023 $210K for 1,491 services; 2024 $207K for 1,499 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 61 | 54 | $2.99 | $182 |
Medicare prescription drug claims, 2024
In 2024, the drug Asif S Kazmi prescribed most often to Medicare patients was Losartan Potassium, with 703 prescriptions and refills. In total Asif S Kazmi wrote 7,069 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 703 | 1,443 | 234 | $5,398 |
| Allopurinol Generic | 513 | 1,097 | 171 | $3,690 |
| Carvedilol Generic | 372 | 671 | 105 | $1,976 |
| Amlodipine Besylate Generic | 321 | 704 | 110 | $1,419 |
| Bumetanide Generic | 236 | 498 | 81 | $4,545 |
| Spironolactone Generic | 211 | 427 | 68 | $1,685 |
| Sevelamer Carbonate Generic | 195 | 292 | 69 | $38K |
| Farxiga Dapagliflozin Propanediol | 187 | 323 | 58 | $181K |
| Potassium Chloride Generic | 164 | 306 | 57 | $2,039 |
| Torsemide Generic | 160 | 268 | 42 | $2,810 |
| Jardiance Empagliflozin | 153 | 233 | 42 | $133K |
| Velphoro Sucroferric Oxyhydroxide | 150 | 170 | 34 | $532K |
| Famotidine Generic | 142 | 302 | 53 | $1,612 |
| Furosemide Generic | 135 | 301 | 51 | $766 |
| Tamsulosin Hcl Generic | 117 | 235 | 37 | $872 |
Brand drugs: - claims; generic drugs: 5,998 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asif S Kazmi $1,078 ($1,078 in general payments such as food, travel and fees) from 13 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $361.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $361 |
| Ardelyx, Inc. ARDX | 8 | $224 |
| Mallinckrodt Hospital Products Inc. | 1 | $94.99 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $81.78 |
| Amgen Inc. AMGN | 4 | $75.29 |
| Scpharmaceuticals Inc. SCPH | 3 | $51.34 |
| Calliditas Therapeutics US Inc. | 2 | $46.93 |
| Travere Therapeutics, Inc. TVTX | 2 | $40.39 |
| Akebia Therapeutics Inc AKBA | 1 | $25.61 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $22.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.